Physician profile
Samuel Shuffler
NPI 1104845999
$4,264.31
in general payments reported to CMS, 2019-2025
36 companies · $604 in 2025
The $604 reported for 2025 was more than what 82% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $828 · 2020: $333 · 2021: $601 · 2022: $555 · 2023: $553 · 2024: $791 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,947.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $746.59 | 2019-2025 | Xtandi, Myrbetriq |
| Abbvie INC. | $539.22 | 2019-2025 | Botox, Lupron Depot |
| Caldera Medical, INC | $392.68 | 2024 | Desara |
| Pfizer INC. | $348.23 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $219.10 | 2023-2025 | Gemtesa, Orgovyx |
| Intuitive Surgical, INC. | $199.81 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $182.32 | 2019-2023 | Xiaflex |
| Coloplast Corp | $173.53 | 2020-2025 | |
| Allergan, INC. | $154.85 | 2019-2022 | |
| Blue Earth Diagnostics | $154.29 | 2019-2022 | |
| Procept Biorobotics Corporation | $125.34 | 2023 | Aquabeam Robotic System |
| Ferring Pharmaceuticals INC. | $93.17 | 2019-2025 | Adstiladrin |
| Boston Scientific Corporation | $85.64 | 2022-2023 | Ams 800 Artificial Urinary Sphincter |
| Olympus America INC. | $85.40 | 2025 | Itind System |
| Dendreon Pharmaceuticals LLC | $75.65 | 2022-2025 | Provenge |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $74.60 | 2021-2024 | Urolift |
| Accord Healthcare, INC. | $67.56 | 2022-2023 | |
| Profound Medical Corp. | $53.66 | 2025 | Tulsa-Pro |
| Antares Pharma, INC. | $48.21 | 2022-2024 | Xyosted |
| Travere Therapeutics, INC. | $45.82 | 2021 | |
| Merck Sharp & Dohme LLC | $40.36 | 2023-2025 | Lynparza, Keytruda |
| Endo USA, INC. | $35.76 | 2024 | Xiaflex |
| Axonics, INC. | $34.47 | 2021-2022 | |
| Urogen Pharma, INC. | $33.83 | 2025 | |
| Janssen Biotech, INC. | $30.49 | 2019-2025 | Erleada |
| Progenics Pharmaceuticals, INC. | $28.68 | 2022 | |
| Dentsply Ih INC. | $28.19 | 2019 | |
| Cardiovascular Systems INC. | $27.21 | 2019 | |
| Urovant Sciences INC | $24.73 | 2021 | |
| Medtronic USA, INC. | $24.69 | 2019-2020 | |
| Myovant Sciences INC. | $18.71 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.10 | 2022 | |
| Medtronic, INC. | $13.99 | 2021 | |
| Telix Pharmaceuticals | $13.67 | 2023 | Illuccix |
| Ethicon US, LLC | $13.58 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.18 | 2024 | Lynparza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Shuffler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.